Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

November 01, 1982; Volume 10,Issue 6
  • You have access
    Analytical controls in drug metabolic studies. II. Artifact formation during chloroform extraction of drugs and metabolites with amine substituents.
    E J Cone, W F Buchwald and W D Darwin
    Drug Metabolism and Disposition November 1982, 10 (6) 561-567;
  • You have access
    Dose-dependent kinetics of quinidine in the perfused rat liver preparation. Kinetics of formation of active metabolites.
    V C Yu, E de Lamirande, M G Horning and K S Pang
    Drug Metabolism and Disposition November 1982, 10 (6) 568-572;
  • You have access
    Salicylate enhancement of renal glucuronide conjugation and tubular excretory transfer of phenols.
    G L Diamond, M W Anders, L M Tremaine and A J Quebbemann
    Drug Metabolism and Disposition November 1982, 10 (6) 573-578;
  • You have access
    Effects of three recombinant human leukocyte interferons on drug metabolism in mice.
    A Parkinson, J Lasker, M J Kramer, M T Huang, P E Thomas, D E Ryan, L M Reik, R L Norman, W Levin and A H Conney
    Drug Metabolism and Disposition November 1982, 10 (6) 579-585;
  • You have access
    Phenobarbital pharmacokinetics in rat as a function of age.
    I M Kapetanovic, D J Sweeney and S I Rapoport
    Drug Metabolism and Disposition November 1982, 10 (6) 586-589;
  • You have access
    Induction of UDP-glucuronosyltransferase activities in Gunn, heterozygous, and Wistar rat livers by pregnenolone-16 alpha-carbonitrile.
    J B Watkins and C D Klaassen
    Drug Metabolism and Disposition November 1982, 10 (6) 590-594;
  • You have access
    5-ethyl-5-phenylhydantoin N-glucuronide, the major urinary metabolite of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
    J H Maguire, T C Butler and K H Dudley
    Drug Metabolism and Disposition November 1982, 10 (6) 595-598;
  • You have access
    Metabolic formation of N- and O-glucuronides of 3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid. Rearrangement of the 1-o-acyl glucuronide.
    F W Janssen, S K Kirkman, C Fenselau, M Stogniew, B R Hofmann, E M Young and H W Ruelius
    Drug Metabolism and Disposition November 1982, 10 (6) 599-604;
  • You have access
    Species-related differences in the stereoselective glucuronidation of oxazepam.
    S F Sisenwine, C O Tio, F V Hadley, A L Liu, H B Kimmel and H W Ruelius
    Drug Metabolism and Disposition November 1982, 10 (6) 605-608;
  • You have access
    Electrophilic reactions of acyl-linked glucuronides. Formation of clofibrate mercapturate in humans.
    M Stogniew and C Fenselau
    Drug Metabolism and Disposition November 1982, 10 (6) 609-613;
  • You have access
    Urinary bivalent sulfur metabolites of phenanthrene excreted by the rat and guinea pig.
    K Lertratanangkoon, M G Horning, B S Middleditch, W S Tsang and G W Griffin
    Drug Metabolism and Disposition November 1982, 10 (6) 614-623;
  • You have access
    Identification of new sulfur-containing metabolites of naphthalene in mouse urine.
    W G Stillwell, M G Horning, G W Griffin and W S Tsang
    Drug Metabolism and Disposition November 1982, 10 (6) 624-631;
  • You have access
    The tissue distribution, metabolism, and excretion of octachlorostyrene in the rat.
    I Chu, D C Villeneuve, V Secours, F M Benoit and A Viau
    Drug Metabolism and Disposition November 1982, 10 (6) 632-635;
  • You have access
    Iminocyclophosphamide as a chemically reactive metabolite of cyclophosphamide.
    C Fenselau, J P Lehman, A Myles, J Brandt, G S Yost, O M Friedman and O M Colvin
    Drug Metabolism and Disposition November 1982, 10 (6) 636-640;
  • You have access
    A pharmacokinetic model to predict exposure of the bladder epithelium to urinary N-hydroxyarylamine carcinogens as a function of urine pH, voiding interval, and resorption.
    J F Young and F F Kadlubar
    Drug Metabolism and Disposition November 1982, 10 (6) 641-644;
  • You have access
    Metabolism and disposition of diphacinone in rats and mice.
    C C Yu, Y H Atallah and D M Whitacre
    Drug Metabolism and Disposition November 1982, 10 (6) 645-648;
  • You have access
    Disposition and metabolism of codorphone in the rat, dog, and man.
    J L Leeling, J V Evans, R J Helms and B A Ryerson
    Drug Metabolism and Disposition November 1982, 10 (6) 649-653;
  • You have access
    Biliary metabolites of the anti-inflammatory drug 2-acetamido-4-(chloromethyl)thiazole.
    J J Rafter and J E Bakke
    Drug Metabolism and Disposition November 1982, 10 (6) 654-656;
  • You have access
    Pharmacokinetics of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with decreasing adipose tissue mass. I. Effects of restricting food intake two weeks after administration of 6-CB.
    P A Wyss, S Mühlebach and M H Bickel
    Drug Metabolism and Disposition November 1982, 10 (6) 657-661;
  • You have access
    Main metabolites of 1-(2-chloroethyl)-3-[1'-(5'-p-nitrobenzoyl-2',3'-isopropylidene)-alpha, beta-D-ribofuranosyl]-1-nitrosourea and 1-(2-chloroethyl)-3-(2',3', 4'-tri-O-acetyl-alpha, beta-D-ribopyranosyl)-1-nitrosourea in rats.
    J C Madelmont, M F Moreau, D Godeneche, J Duprat, R Plagne and G Meyniel
    Drug Metabolism and Disposition November 1982, 10 (6) 662-666;
  • You have access
    Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man.
    M Claesen, M A Moustafa, J Adline, D Vandervorst and J H Poupaert
    Drug Metabolism and Disposition November 1982, 10 (6) 667-671;
  • You have access
    Theobromine metabolism in man.
    J O Miners, J Attwood and D J Birkett
    Drug Metabolism and Disposition November 1982, 10 (6) 672-675;
  • You have access
    Tissue distribution of 14C-diazepam and its metabolites in rats.
    Y Igari, Y Sugiyama, Y Sawada, T Iga and M Hanano
    Drug Metabolism and Disposition November 1982, 10 (6) 676-679;
  • You have access
    Disposition of phencyclidine in mice after smoke exposure.
    A S Freeman and B R Martin
    Drug Metabolism and Disposition November 1982, 10 (6) 680-684;
  • You have access
    In vitro metabolism of 1-phenyl-1-cyclohexene, a pyrolysis product of phencyclidine.
    B R Martin, B B Bailey, H Awaya, E L May and N Narasimhachari
    Drug Metabolism and Disposition November 1982, 10 (6) 685-689;
  • You have access
    Metabolism of phencyclidine. The role of iminium ion formation in covalent binding to rabbit microsomal protein.
    D P Ward, A J Trevor, A Kalir, J D Adams, T A Baillie and N Castagnoli
    Drug Metabolism and Disposition November 1982, 10 (6) 690-695;
  • You have access
    A new pyrrolizidine alkaloid metabolite, 19-hydroxysenecionine isolated from mouse hepatic microsomes in vitro.
    D F Eastman and H J Segall
    Drug Metabolism and Disposition November 1982, 10 (6) 696-699;
  • You have access
    Cytochrome P-455-nm complex formation in the metabolism of phenylalkylamines. VI. Structure--activity relationships in metabolic intermediary complex formation with a series of alpha-substituted 2-phenylethylamines and corresponding N-hydroxylamines.
    B Lindeke, U Paulsen-Sörman, G Hallström, A H Khuthier, A K Cho and R C Kammerer
    Drug Metabolism and Disposition November 1982, 10 (6) 700-705;
  • You have access
    Tissue metabolism and distribution of methotrexate in rabbits.
    M L Chen and W L Chiou
    Drug Metabolism and Disposition November 1982, 10 (6) 706-707;
  • You have access
    A study of methylphenidate in man with respect to its major metabolite.
    E Redalieu, M F Bartlett, L M Waldes, W R Darrow, H Egger and W E Wagner
    Drug Metabolism and Disposition November 1982, 10 (6) 708-709;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 10, Issue 6
1 Nov 1982
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Predictable Cross-Species Translation of GalNAc-Conjugated siRNA
  • Cannabinoid Metabolites as CYP450 Inhibitors
  • ADME of Therapeutic Proteins
  • PK and Biodistribution of Therapeutic Proteins
  • An IQ Perspective of Therapeutic Protein Biotransformation
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics